Food-Effect and Metabolism Study in Healthy Subjects
NCT03062982 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2017-02-24
Summary
This study evaluates the food-effect of one-dose Fluzoparib in healthy subjects. The participants receive Fluzoparib 120mg in fed state in Period 1 followed by administration of Fluzoparib 120mg in fasted state in Period 2.
Conditions
Interventions
- DRUG
-
Fluzoparib
2 doses separated by 7 days.
Sponsors & Collaborators
-
Jiangsu HengRui Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-21
- Primary Completion
- 2017-01-04
- Completion
- 2017-01-04
Countries
- China
Study Locations
More Related Trials
-
Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma
NCT00817258 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma
NCT00816855 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
NCT06132828 ·Status: RECRUITING ·Phase: PHASE1
-
Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases
NCT05129202 ·Status: COMPLETED
-
A Study to Investigate FP002 in Subjects With Advanced Malignancies
NCT05982080 ·Status: RECRUITING ·Phase: PHASE1
-
SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.
NCT03558191 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage
NCT03403829 ·Status: UNKNOWN ·Phase: PHASE3
-
SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma
NCT04937972 ·Status: RECRUITING ·Phase: PHASE2
-
The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors
NCT02031731 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
NCT01432951 ·Status: COMPLETED ·Phase: PHASE1
-
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
NCT01614938 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects
NCT03121716 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
NCT06832982 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT07136142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
NCT04557020 ·Status: RECRUITING ·Phase: PHASE3
-
Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma
NCT03908372 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)
NCT00817583 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC
NCT05780294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma
NCT01536223 ·Status: UNKNOWN ·Phase: PHASE3
-
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
NCT05520814 ·Status: UNKNOWN ·Phase: PHASE2
-
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05340270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase I Clinical Study of Metatinib Tromethamine Tablet
NCT02004548 ·Status: COMPLETED ·Phase: PHASE1
-
S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT03668366 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
NCT02575547 ·Status: COMPLETED
-
Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy
NCT04978012 ·Status: RECRUITING ·Phase: PHASE2